Allogene Therapeutics, Inc.
ALLOBiotechnology
$1.18−5.60%As of Oct 30vs prior close
- Market cap
- $407.7M
- P/E (TTM)
- –
- From 52W high
- −61.44%
- EPS (LTM)
- -$0.77
- Revenue (LTM)
- $2.5M
- Net margin
- -7304.80%
Nomior Score
37
Speculative ChargeSpeculativeBottom 25% of the scored universe
Growth74
Quality29
Value28
Momentum59
Resilience26
Growth
$2.5Mrevenue, LTM
YE19 $0LTM $2.5M
Connections
Revenue to profitQ2 YE26
The operating loss was 1011% of revenue, narrower by 5302 pts on a year.
Who owns it
2funds